The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Snooty, what time is the AGM tomorrow?
5teveW - usual MM squeeze of the SP ahead of AGM next Tuesday. I expect some relief soon.
Lord - yes I hope that news comes thick and fast - we seem to be dropping again!
Lord - yes I hope that news comes thick and fast - we seem to be dropping again!
News of $7.5m funding and single-digit future licensing fee seems to have had very modest impact so far. Let's hope it's followed up with some concrete deals in the weeks and months ahead. AGM set for Tuesday 14th November, though it looks from the voting schedule to be standard stuff.
Appears to have hit the ground running. So far so good...
is this finally the start of some good news flow to push this up to where it belongs?
looks positive TBF.
riddance.
and Scott is leaving the company.
Xenetic Biosciences Appoints Jeffrey F. Eisenberg as Chief Executive Officer
I gather Scott is still CEO but off the Board.
Here we go again back down - perhaps the stocktwits can push this back up to $4.5 like at the start of the month?? Also, re another thread, I am not sure how involved Scotty is with the company anymore
Hola ! Buenos dias from a HOT country - Spain.☺ I'm not confident at all on the clinical trials, because there is not much information available. the latest trial info is October 2017. If you go to XEN website (https://www.xeneticbio.com/product-pipeline/xbio-101) you will see a clinical trials link that doesn't work. However, you can go to https://www.clinicaltrials.gov/ct2/show/NCT02064725?term=NCT02064725&rank=1 which shows an ongoing clinical trial managed by Kevelt AS. The XEN website refers to its XBIO 101 drug which is not mentioned in the clinical trial. The clinical trial mentions 'Virexxa'. and no news since Jan 2017. If you look for sodium cridanimod on the clinical trials site, you will see XEN responsible for a trial at: https://www.clinicaltrials.gov/ct2/show/NCT03077698?term=Sodium+Cridanimod&rank=2 This study will finish on Nov 30, 2020. There are several hospitals that are recruiting and some not recruiting yet. The 'other' name for sodium cridanimod is Megestrol Acetate. There are 74 studies listed about this drug. Scotty hasn't been forthcoming with any news and I am not sure that XEN can survive until 2020 for the results of its drug in the trial. The XEN or XBIO website has not been updated and Scotty appears to be burying his head in the sand or am I wrong?
that SIIL link, typically for India, doesn't appear to have been updated for at least five years ("Lipoxen" for Chrissake). How confident are you that there is current work being done by SIIL using PolyXen? Can you point to any recent publication of results?
Seriously thinking of selling up..no more fun😕
Hi Par Hope you are right but why does it still say Lipoxin is the information upto date. Cheers Clem
me too! putting it all into bitcoin could prove less volatile!
sick of the share price being yanked up and down week after week, month after month, to yield enough shares to maintain our qualification for NASDAQ; meanwhile no news at all. Approaching five months silence now since the SHP656 debacle. Sick of this sh*t.
Wish the bloody share price could stay up for 400 hours.
I hope. I have a hunch that the trial results for ErepoXen are almost out. The previous trials showed that Erepoxen maintained EPO protein levels about 400 hours compared to only 22 hours or standard recombinant EPO protein. This quite significant for chronic kidney disease patients. Check out www.seruminstitute.com/product_horizon.php. Talking about commercialization?
anyone know whats up yet?
whatever you said is working, keep it up!
whatever you said is working, keep it up!
https://screenshots.firefox.com/k9eWUWWPpMAHwmpX/stocktwits.com Believe it or not, haha.